Investors & Media

Corporate Profile

Aura Biosciences is leveraging a novel targeted oncology platform to develop a potential new standard of care across multiple cancer indications, with an initial focus on ocular and urologic oncology.

 


Recent Financial Filings

Filing date Form Filing Group
144
Other
SC 13G/A
Other
SC 13G/A
Other

Stock Information

AURA BIOSCIENCES


February 27, 2024 1:45 AM EST
Data Provided by Refinitiv. Minimum 15 minutes delayed.